Company news

Summit Therapeutics Inc. news

Latest news releases, newest first. Pick a year for every news release, call and deck from that year.

View company

Summit Announces Effectiveness of Scheme of Arrangement and Completion of Redomiciliation to Delaware, USA

September 17, 2020

Summit Therapeutics Announces U.K. Court Approval of Scheme

September 16, 2020

Summit Announces Results of Court Meeting and General Meeting

August 18, 2020

Summit Announces Intention to Redomicile its Holding Company to the United States

July 15, 2020

Summit Announces Publication of Phase 2 Clinical Analyses of Gut Microbiome Health

July 12, 2020

Summit Appoints Michael Donaldson as Chief Financial Officer

June 7, 2020

Summit Therapeutics Reports Financial Results and Operational Progress for the First Quarter and Three Months Ended March 31, 2020

June 1, 2020

Summit Therapeutics Reports Financial Results for the Fourth Period and Eleven Months Ended December 31, 2019, and Operational Progress

April 29, 2020

Summit Appoints Robert W. Duggan as Chief Executive Officer

April 13, 2020

Summit Appoints Robert W. Duggan as Executive Chairman

February 25, 2020

Summit Presents In Vivo Proof of Concept Data for New Mechanism Antibiotics Targeting Enterobacteriaceae in Oral Session at ECCMID 2019

April 13, 2019

Summit’s Pipeline Expands with Series of New Mechanism Antibiotics Targeting Enterobacteriaceae

April 2, 2019

Summit Therapeutics to Present at H. C. Wainwright & Co. Global Life Sciences Conference

April 1, 2019

← Newer news releases

Calls

The 5 newest of 11 calls. Every call is listed under its year.

Decks

The 5 newest of 32 decks. Every deck is listed under its year.